Jie Sun

Title: Innovations in Cancer Treatment by Jie Sun

Introduction

Jie Sun is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of cancer research through his innovative patents. His work focuses on enhancing macrophage-mediated antibody-guided cancer cell or tumor eradication.

Latest Patents

Jie Sun holds a patent for "Compositions and methods for enhancing macrophage-mediated antibody guided cancer cell or tumor eradication." This patent includes Shp2- and Spleen tyrosine kinase (Syk)-integrated sensing and actuating protein (iSNAP) chimeric proteins. These proteins comprise a bi-phosphorylatable peptide, a bisphosphoryl tyrosine-based activation (BTAM) motif, and a Fluorescent Protein Förster Resonance Energy Transfer (FRET) pair. The invention also features a truncated Shp2 domain and a phosphatase or kinase domain. The engineered cells and methods described in the patent aim to promote an anti-cancer inflammatory response and enhance the eradication of cancer cells.

Career Highlights

Jie Sun is affiliated with the University of California, where he continues to advance his research in cancer treatment. His innovative approaches have garnered attention in the scientific community, contributing to the development of new therapeutic strategies.

Collaborations

Jie Sun has collaborated with notable researchers, including Yingxiao Wang and Shu Chien. These partnerships have further enriched his research and expanded the impact of his work in the field of cancer therapy.

Conclusion

Jie Sun's innovative contributions to cancer treatment through his patent demonstrate his commitment to advancing medical science. His work has the potential to significantly improve cancer therapies and patient outcomes.